Cannabis Bioscience International Holdings (CBIH) Cash from Operations (2023 - 2026)
Cannabis Bioscience International Holdings' (CBIH) quarterly Cash from Operations came in at 14597.0 in Q1 2026, up 82.37% year-on-year from 8003.91 in Q1 2025, and down 165.74% quarter-over-quarter from 5493.0 in Q4 2025.
Cannabis Bioscience International Holdings (CBIH) Cash from Operations (2023 - 2026) Analysis & Trends
Cannabis Bioscience International Holdings has disclosed Cash from Operations across 4 years of filings, most recently posting 14597.0 for Q1 2026.
- Cash from Operations for Q1 2026 came in at 14597.0, up 82.37% year-over-year; the trailing twelve-month figure through Feb 2026 was 268114.0 (up 25.47% YoY), and the FY2025 annual result was 329627.0, up 31.24% from the prior year.
- Cash from Operations came in at 14597.0 for Q1 2026 at Cannabis Bioscience International Holdings, down from 5493.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 5493.0 in Q4 2025 to a low of 221247.0 in Q4 2023.
- The 4-year median for Cash from Operations is 82812.0 (2025), against an average of 101680.08.
- Across the five-year window, Cash from Operations jumped 95.49% in 2024 and plunged 812.43% in 2025, its largest moves.
- Cannabis Bioscience International Holdings' Cash from Operations stood at 221247.0 in 2023, then soared by 67.42% to 72090.0 in 2024, then surged by 92.38% to 5493.0 in 2025, then sank by 165.74% to 14597.0 in 2026.
- The last three Cash from Operations figures came in at 14597.0 (Q1 2026), 5493.0 (Q4 2025), and 103712.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -40.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 401.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 463.30 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 145.80 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 13.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -165.74 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 89.36 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 125.13 Mn |
| 10 | Cannabis Bioscience International Holdings | - | - | 8,160.00 | -14,597.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -14,597.00 |
| Feb 28, 2026 | -14,597.00 |
| Nov 30, 2025 | -5,493.00 |
| Nov 30, 2025 | -5,493.00 |
| Aug 31, 2025 | -103,712.00 |
| Aug 31, 2025 | -103,712.00 |
| May 31, 2025 | -144,312.00 |
| May 31, 2025 | -144,312.00 |
| Feb 28, 2025 | -82,812.00 |
| Feb 28, 2025 | -82,812.00 |
| Nov 30, 2024 | -72,090.00 |
| Nov 30, 2024 | -72,090.00 |
| Aug 31, 2024 | -30,413.00 |
| Aug 31, 2024 | -30,413.00 |
| May 31, 2024 | -174,439.00 |
| May 31, 2024 | -174,439.00 |
| Feb 29, 2024 | -9,076.00 |
| Feb 29, 2024 | -9,076.00 |
| Nov 30, 2023 | -221,247.00 |
| Nov 30, 2023 | -221,247.00 |